Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Soufflé gets $135M for three RNA medicines

A Bob Langer-affiliated startup has collected a megaround to advance at least three experimental oligonucleotide medicines. Soufflé Therapeutics uncorked a fresh $135 million in VC backing on Tuesday. The capital will ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 13 October →